Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4

2(40.0%)

N/A

2(40.0%)

Phase 1

1(20.0%)

5Total

Phase 4(2)

N/A(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06853574Not ApplicableNot Yet Recruiting

Ventriculo-arterial Coupling and Myocardial Work in Sepsis and Septic Shock

Role: lead

NCT06368908Not ApplicableRecruiting

Transcutaneous Functional Magnetic Muscle Stimulation in Critically Ill

Role: lead

NCT00548288Phase 1Not Yet Recruiting

Effect of Local Pamidronate in Preventing Bone Loss After Total Hip Arthroplasty

Role: lead

NCT06360770Completed

Assessement of Microcirculation With NIRS Predicts Sepsis Development in Patients With Severe Covid-19 Pneumonia

Role: lead

NCT05426980Completed

Artificial Intelligence in Predicting Progression in Multiple Sclerosis Study

Role: collaborator

NCT05857085Phase 4Completed

Novel Therapeutics and Endothelial Dysfunction in T1DM Patients

Role: lead

NCT04355026Phase 4Unknown

Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia

Role: lead

NCT02804009Unknown

Elective Coronary Angiography and Anxiety Study

Role: lead

NCT02550808Unknown

Metabolic Changes in Patients With Chronic Cardiopulmonary Disease

Role: lead

All 9 trials loaded